For much of the pandemic, the prevailing public narrative presented by many governments and major media organisations was that COVID-19 most likely originated through a natural spillover event associated with the Huanan Seafood Wholesale Market in Wuhan. Over the past several years, however, congressional testimony, declassified intelligence material, internal scientific communications and official audits have prompted renewed scrutiny of that narrative.
This opening investigation maps the institutions, funding pathways and principal figures behind an international system of pathogen surveillance, coronavirus experimentation and biological-threat research. It distinguishes documented relationships from disputed interpretations and asks whether the public was ever shown the complete picture.
How a global pathogen research network, billions in public funding and newly released documents are reshaping the debate
Editorial Note
This article examines a scientifically and politically contested subject. It draws upon official audits, government records, congressional material, scientific publications, declassified intelligence releases and publicly reported correspondence.
Where the evidence establishes a funding relationship, institutional connection or official statement, that is presented as documented fact. Where causation, intent or criminal liability remains disputed, the uncertainty is stated plainly.
The purpose of The Pathogen Files is not to substitute one unquestioned narrative for another. It is to follow the documentary record.
Part One
The Story Was Always Bigger Than a Market
The Huanan Seafood Wholesale Market became the defining image of the pandemic’s beginning: crowded stalls, live animals, close human contact and the apparent ingredients for a natural zoonotic spillover.
Early cases were associated with the market, and the natural-origin hypothesis remained scientifically plausible. Yet the public discussion was often simplified into something more certain: a bat virus had crossed through an animal host, entered the market and begun spreading among humans.
The alternative possibility—that SARS-CoV-2 emerged through a laboratory-associated incident—was frequently treated not merely as unproven, but as beyond legitimate discussion.
That confidence became closely associated with the March 2020 paper The Proximal Origin of SARS-CoV-2. Its authors argued that the virus was not a deliberately manipulated laboratory construct and said laboratory-based scenarios were not plausible.
Documents subsequently released through congressional investigations show that scientists involved in the early origins discussions privately considered laboratory adaptation, tissue culture, furin cleavage sites and other mechanisms more extensively than the public presentation suggested. The source material supplied to eLocal reports continuing private disagreement and uncertainty among researchers associated with the paper.
That does not, by itself, prove a laboratory origin.
It does establish why the story cannot be understood solely by examining the wet market. The laboratories, funding agencies, universities, intelligence organisations and international research partnerships surrounding coronavirus science must also be examined.
The World After SARS
The modern pathogen-research network expanded rapidly after the original SARS outbreak of 2003.
SARS demonstrated that a previously unknown coronavirus could cross into humans, travel internationally and place entire health systems under strain. Governments responded by investing in wildlife sampling, disease surveillance, virus sequencing, vaccine platforms and research intended to identify potentially dangerous pathogens before they caused the next outbreak.
The public-health logic was compelling.
Scientists would locate viruses in animals, study their genetic characteristics, determine whether they could infect human cells and develop medical countermeasures in advance.
But the system gradually moved beyond passive observation.
Researchers developed reverse-genetics platforms that could reconstruct viruses from genetic sequences. They created chimeric viruses by combining components from different strains. They altered spike proteins, adapted pathogens to cell cultures and animal models, and tested which changes affected infectivity, host range or virulence.
These methods can produce valuable knowledge. They can also create new risks.
The central governance question became whether the potential public-health benefit justified experiments capable of enhancing a pathogen’s biological functions—and whether officials could adequately supervise work distributed across institutions and national borders.
Ralph Baric and Coronavirus Engineering
Few scientists occupied a more important position in this field than Dr Ralph Baric of the University of North Carolina.
Baric spent decades developing coronavirus reverse-genetics systems and experimental methods that allowed researchers to reconstruct and modify viruses. His laboratory also developed human ACE2 transgenic mice, which carried the human receptor used by SARS-related coronaviruses to enter cells.
The material supplied to eLocal reports that Baric confirmed providing his NIH-funded ACE2 mouse model to Dr Shi Zhengli’s laboratory at the Wuhan Institute of Virology. Such models could be used to assess naturally occurring or experimentally altered coronaviruses that could not efficiently infect ordinary laboratory mice.
The sharing of an animal model is not evidence that SARS-CoV-2 was created in a laboratory.
It is evidence of a close scientific relationship connecting American taxpayer-funded research tools, UNC’s coronavirus expertise and the Wuhan Institute’s bat-virus programme.
Baric also became central to the later debate over what constituted gain-of-function research.
According to the congressional testimony discussed in the supplied source, Baric described experiments contemplated under a DARPA programme in direct terms:
“That’s a gain-of-function experiment. There’s no other way to think about it.”
The quotation matters because officials had spent years debating whether certain coronavirus experiments met narrower government definitions of gain of function. Baric’s reported answer reflected the broader scientific meaning: an experiment intended to determine whether a change gives a virus a new or enhanced property.
EcoHealth Alliance: The International Bridge
EcoHealth Alliance, led by Dr Peter Daszak, became one of the principal organisations linking US agencies with international virus-research programmes.
EcoHealth applied for government funding, coordinated wildlife-sampling projects, organised international partnerships and distributed portions of grant money to subrecipients.
One important NIH award funded research into bat coronaviruses and included work conducted through the Wuhan Institute of Virology.
A 2023 audit by the US Department of Health and Human Services Office of Inspector General examined three NIH awards to EcoHealth totalling approximately US$8 million. Those awards included approximately US$1.8 million in subawards to eight institutions, including the Wuhan Institute. (HHS Office of Inspector General)
The audit did not conclude that this research created SARS-CoV-2.
It did find serious weaknesses in oversight.
The Inspector General reported that NIH did not effectively monitor EcoHealth or take timely action after identifying potential risks. A required progress report arrived late, and NIH failed to follow up for almost two years. When the report was eventually reviewed, NIH concluded that research results had met a viral-growth reporting threshold contained in the grant’s special conditions. (HHS Office of Inspector General)
The audit also found that EcoHealth could not obtain all requested scientific documentation from the Wuhan Institute and identified US$89,171 in unallowable costs.
The finding goes to the heart of this investigation.
American agencies financed research overseas through an intermediary, yet later struggled to obtain records needed to understand exactly what had occurred.
USAID and the Virus-Discovery Pipeline
Another funding stream came through the US Agency for International Development and its PREDICT programme.
PREDICT operated from 2009 to 2020 as part of the Emerging Pandemic Threats initiative. It was designed to identify viruses in wildlife before they crossed into human populations.
The programme helped fund field collection, sequencing, cataloguing, training and international sharing of viral material and data. EcoHealth Alliance and the Wuhan Institute participated in aspects of this wider virus-surveillance system.
PREDICT was not formally created as a virus-engineering programme. Its declared function was discovery and early warning.
Yet the source material supplied to eLocal argues that it helped establish the scientific infrastructure later used by more advanced research: sample collections, genetic databases, trained researchers, laboratory partnerships and international channels through which viruses and sequences could move.
This distinction is important.
A surveillance programme can be peaceful and legitimate while still providing the raw material, knowledge and institutional relationships required for dual-use experimentation.
DARPA, DEFUSE and the Furin Cleavage Site
The proposal known as DEFUSE became one of the most controversial documents in the origins debate.
Submitted to the Defense Advanced Research Projects Agency, DEFUSE proposed collecting SARS-related bat coronaviruses, analysing their pandemic potential and experimentally testing modifications.
One proposed component involved inserting furin cleavage sites into coronavirus spike proteins.
The presence of a furin cleavage site in SARS-CoV-2 later attracted attention because it can affect how efficiently a virus enters cells and because the feature was unusual among its closest known viral relatives.
According to the congressional testimony described in the supplied material, Baric confirmed that his UNC laboratory would have performed the proposed insertion work. He also acknowledged that inserting the feature to determine whether it changed the viral phenotype would constitute gain-of-function research.
DARPA rejected DEFUSE.
Baric testified that the experiments proposed under the rejected application were not performed as part of that project.
No publicly released document presently establishes that DEFUSE was secretly implemented exactly as written or that it produced SARS-CoV-2.
The unresolved question is whether substantially similar experiments proceeded through another grant, contract or research programme involving some of the same institutions.
The supplied source acknowledges that current documents do not conclusively prove that the specific furin-cleavage-site experiments proposed to DARPA were later carried out under NIH funding.
That is precisely the type of question later instalments of The Pathogen Files will examine against grant applications, progress reports and experimental records.
Anthony Fauci and NIAID
Dr Anthony Fauci led the National Institute of Allergy and Infectious Diseases from 1984 until 2022.
NIAID sat at the centre of US infectious-disease funding and supported the EcoHealth award that included subawards connected to Wuhan.
A federal research grant is not personally approved line by line by a single agency director. Applications pass through peer review, programme staff and institutional processes.
Nevertheless, Fauci was the head of the funding institute and later became the most prominent public defender of its actions.
During a May 2021 Senate hearing, Fauci told Senator Rand Paul that NIH had not funded gain-of-function research at the Wuhan Institute.
Fauci maintained that he was using the narrower federal regulatory definition associated with research on enhanced potential pandemic pathogens.
Critics argued that this gave Congress and the public a misleading impression because experiments could enhance viral properties in the ordinary scientific sense without being classified by the government as regulated gain-of-function research.
The dispute intensified when former acting NIH director Lawrence Tabak acknowledged that the term could describe the Wuhan work under the broader scientific definition. A House Select Subcommittee later accused Fauci of maintaining a misleading denial, while Fauci continued to defend his interpretation of the regulatory framework. (Oversight Committee)
A semantic disagreement is not automatically criminal perjury.
Proving perjury requires evidence that a person knowingly made a materially false statement under oath.
But the clash between Fauci’s categorical public language, broader scientific usage and later NIH testimony remains central to the accountability question.
The February 2020 Call
Fauci also participated in the confidential scientific discussions that preceded Proximal Origin.
On 1 February 2020, Wellcome Trust director Jeremy Farrar convened leading scientists and officials to discuss whether the emerging virus might have arisen naturally or through a laboratory-associated event.
Participants included Fauci, NIH director Francis Collins and several scientists who would become authors of Proximal Origin. Baric has also confirmed his participation in the call, according to the supplied source.
There is nothing inherently improper about officials urgently consulting experts during the beginning of a pandemic.
The issue is whether the scientific uncertainty discussed privately was subsequently communicated honestly to the public.
The newly released messages described in the source show continuing private discussion about laboratory adaptation, tissue culture, furin cleavage sites, host-range experiments and Wuhan research after the public-facing paper strongly favoured natural emergence.
The evidentiary question is not whether every participant privately believed in a lab leak.
It is why a debate that remained scientifically active was presented publicly with such confidence.
A Changing Intelligence Position
The official US intelligence presentation has also changed over time.
In 2023, ODNI released a report required by the COVID-19 Origin Act examining potential links between the Wuhan Institute and the pandemic. That release reflected an intelligence community still divided over the virus’s origin and did not offer a universally accepted conclusion. (Director of National Intelligence)
In June 2026, under Director of National Intelligence Tulsi Gabbard, ODNI adopted a much more forceful position.
Gabbard’s office released documents and alleged that Fauci-funded Wuhan research was connected to the accidental laboratory leak that began the pandemic. ODNI also accused Fauci of influencing intelligence assessments and making false statements to Congress about his contacts with intelligence officials. (Director of National Intelligence)
These are consequential allegations from the office responsible for coordinating the US intelligence community.
They are not the same as a judicial verdict or an uncontested scientific finding.
The underlying documents, witness accounts, dissenting analyses and chain of inference must be examined individually. But the 2026 release demonstrates how far the official debate has moved from the period when laboratory-origin discussion was commonly dismissed as misinformation.
Fauci’s Pre-emptive Pardon
On 20 January 2025, President Joe Biden issued a pre-emptive pardon covering Anthony Fauci.
Biden said Fauci and other public servants faced threats of politically motivated prosecution and stated that the pardon should not be interpreted as an acknowledgement of wrongdoing. (The American Presidency Project)
The timing and breadth of the protection remain significant.
The pardon was issued before the 2026 ODNI releases and before the public examination of all the material now emerging through congressional and intelligence channels.
A pardon does not prove guilt.
It also does not erase congressional testimony, prevent historical scrutiny or resolve questions about funding and oversight.
It does, however, limit one potential avenue of federal criminal accountability for conduct covered by its terms.
The issue is therefore not simply whether Fauci could be prosecuted.
It is whether the public can obtain a complete account from a central official whose agency financed relevant research and whose public statements helped shape the origins narrative.
The Ukraine Biological-Research Network
The Wuhan story developed within one international system. A separate but related system operated through US-supported biological-threat-reduction programmes abroad.
After the collapse of the Soviet Union, Congress established the Nunn–Lugar Cooperative Threat Reduction programme to secure weapons, materials and scientific expertise inherited by former Soviet states.
The United States later supported biological safety, disease surveillance and diagnostic facilities in Ukraine.
The Department of Defense says it invested approximately US$200 million in Ukraine from 2005 and supported 46 laboratories, health facilities and diagnostic sites. It describes the facilities as Ukrainian-owned and operated and says their purpose was public health, agricultural safety, disease surveillance and the secure handling of dangerous pathogens—not offensive biological-weapons development. (U.S. Department of War)
The Pentagon’s account must be included because claims that every supported facility was a US biological-weapons laboratory go beyond the publicly established evidence.
But the opposite claim—that no US-supported biological laboratory or dangerous-pathogen programme existed in Ukraine—was also inaccurate.
The facilities existed. US money, equipment, contractors and training were involved.
Victoria Nuland’s Testimony
During a March 2022 Senate Foreign Relations Committee hearing, Victoria Nuland was asked whether Ukraine possessed chemical or biological weapons.
She replied that Ukraine had “biological research facilities” and said the United States was concerned that Russian forces might gain control of research materials held there.
The official Senate hearing record identifies Nuland as the witness and includes the hearing transcript. (foreign.senate.gov)
Nuland did not admit that Ukraine operated an offensive biological-weapons programme.
Her answer did confirm that biological research facilities containing sensitive materials existed and that the United States considered their possible capture a serious concern.
This distinction is essential to credible reporting.
The documented issue is not that every foreign biological facility was designed as a weapon laboratory. It is that public-health, biodefence and threat-reduction programmes can involve hazardous pathogens and dual-use capabilities, especially when facilities are operating inside a war zone.
Tulsi Gabbard and the Global Biolab Programme
In June 2026, Gabbard’s ODNI also released material stating that the US government had funded more than 120 biological laboratories in over 30 countries.
The release included Ukraine and said intelligence reporting had warned that at least one US-funded Ukrainian laboratory likely housed dangerous pathogens while remaining vulnerable to attack, seizure or damage. (Director of National Intelligence)
ODNI further alleged that some overseas laboratories had conducted dangerous gain-of-function work with inadequate transparency and oversight.
This release does not establish that Ukrainian laboratories created COVID-19 or participated directly in its development.
It broadens the investigation.
It places Wuhan and Ukraine within a larger publicly funded architecture of overseas laboratories, pathogen collections, scientific collaborations, defence programmes and fragmented accountability.
Nathan Wolfe, Metabiota and the Private Sector
Metabiota, founded by American virologist Nathan Wolfe, operated within this broader biological-risk industry.
The company worked as a subcontractor to Black & Veatch under Defense Threat Reduction Agency programmes in Ukraine. Its reported activities included biosafety training, diagnostics, disease surveillance and support for laboratory personnel. (The Washington Post)
Black & Veatch itself describes extensive DTRA-funded work involving laboratory construction and renovation, biosafety upgrades, training and collaborative biological research across Ukraine. (BV)
Metabiota also attracted private investors, including a Rosemont Seneca-affiliated investment entity associated with Hunter Biden.
Published reporting based on business records and emails described attempts to connect Metabiota with Burisma for a proposed science initiative in Ukraine. The available evidence supports an overlap among private investment, Ukrainian business relationships and an existing Pentagon biological-security contractor. (The Washington Post)
It does not yet establish that Hunter Biden personally financed biological-weapons development or that Burisma money funded pathogen-engineering experiments.
That distinction will remain central when the financial trail is examined in depth.
Hunter Biden’s Broad Pardon
President Biden granted Hunter Biden a full and unconditional pardon on 1 December 2024.
It covered federal offences Hunter “committed or may have committed or taken part in” between 1 January 2014 and 1 December 2024. (The American Presidency Project)
The pardon therefore extended beyond the tax and firearms cases for which Hunter had already faced prosecution.
Its coverage began in the same year his Ukrainian business relationships, Burisma role and Metabiota-related correspondence became relevant.
The pardon does not establish criminal conduct involving Metabiota, Ukraine or biological research.
But, as with Fauci’s pardon, its breadth limits future federal prosecution for otherwise covered conduct during a period that remains under historical and congressional examination.
Legal immunity and factual accountability are not the same thing.
The public can still ask what relationships existed, what services were proposed, whether money moved between connected entities and whether official access carried private commercial value.
One System, Many Funding Streams
The network now coming into view was not controlled through a single agency.
NIH and NIAID funded biomedical research.
USAID supported international pathogen surveillance.
DARPA solicited advanced scientific proposals.
The Department of Defense and DTRA financed biological-threat-reduction programmes abroad.
EcoHealth Alliance coordinated grants and international collaborations.
Universities developed experimental platforms.
Private contractors built laboratories and trained personnel.
Companies such as Metabiota provided scientific expertise and biological-risk services.
Foreign laboratories collected viruses, stored pathogens and conducted research under their own national institutions.
Each participant could claim responsibility for only one part of the system.
That fragmentation created an accountability gap.
A funding agency might review a grant but never directly observe every experiment.
A prime recipient might depend upon reports from foreign subcontractors.
A contractor might build a facility but not control later research.
A university might share an animal model without controlling every future use.
A national intelligence service might possess information unavailable to health regulators.
By the time a crisis occurred, no single democratic institution necessarily held the complete record.
What the Documents Establish
Several conclusions can now be stated without speculation.
The United States funded international coronavirus research before the pandemic.
US-supported institutions collaborated with the Wuhan Institute of Virology.
EcoHealth Alliance distributed NIH grant money through foreign subawards.
The HHS Inspector General documented serious weaknesses in NIH and EcoHealth oversight. (HHS Office of Inspector General)
Gain-of-function experiments were proposed, debated and conducted in varying forms, although disputes continued over the regulatory meaning of the term.
Scientists privately considered laboratory-associated scenarios more seriously than the public-facing consensus initially conveyed.
The United States also supported biological laboratories and disease-surveillance facilities in Ukraine and many other countries. (U.S. Department of War)
Both Anthony Fauci and Hunter Biden received unusually broad presidential pardons covering periods relevant to ongoing public scrutiny. (The American Presidency Project)
These facts do not answer every question.
They make further investigation unavoidable.
What Has Not Yet Been Proven
The current public record does not provide a complete and universally accepted chain showing which experiment, if any, produced SARS-CoV-2.
It does not conclusively establish that the rejected DEFUSE proposal was implemented exactly as written.
It does not prove that Ukraine’s public-health and threat-reduction facilities formed an offensive biological-weapons programme.
It does not demonstrate that Ukrainian laboratories participated directly in the creation of COVID-19.
It does not establish that Hunter Biden personally financed pathogen engineering.
It does not, without a legal finding, establish that Anthony Fauci committed perjury or another federal offence.
Those boundaries strengthen the investigation.
Documented relationships should not be weakened by claims that go beyond the evidence.
Why This Matters to New Zealand
New Zealand did not direct the programmes examined here, but it lived through their consequences.
Our borders were closed.
Businesses failed.
Families were separated.
Emergency powers expanded.
Public debt increased.
Mandates affected employment and social participation.
Children lost classroom time, and public trust in government, medicine and journalism was deeply tested.
New Zealand relied heavily upon international scientific institutions and foreign-origin advice when adopting extraordinary measures.
That gives New Zealanders a direct interest in knowing whether the origins evidence was complete, whether institutional conflicts were disclosed and whether officials distinguished genuine scientific uncertainty from settled fact.
The National Interest Test asks:
Did the international pathogen-research system make New Zealand safer?
Did our government independently test the advice it received?
Were uncertainties communicated honestly?
Were emergency powers proportionate and accountable?
What safeguards should apply before New Zealand participates in future genomic-surveillance, pandemic-preparedness or pathogen-research programmes?
And if overseas research financed by foreign taxpayers can impose enormous consequences on New Zealand, where does responsibility ultimately lie?
The Investigation Begins
This opening feature does not close the COVID-origins debate.
It shows why the original public story was incomplete.
The pandemic did not emerge into a scientific vacuum. It appeared within a mature international system of virus discovery, laboratory experimentation, government funding, defence research, private contracting and global institutional influence.
The question is no longer whether that system existed.
It did.
The question is whether democratic governments genuinely understood and controlled what they were financing.
Over the coming instalments, The Pathogen Files will examine the grants, agencies, correspondence, testimony, scientific papers, pardons and funding relationships one strand at a time.
The investigation will follow the money.
It will follow the laboratories.
It will follow the decisions.
And it will apply the question at the heart of every eLocal investigation:
Does this make New Zealand stronger—and who is accountable when it does not?
Coming Next
The Pathogen Files — Part Two
Following the Money
How NIH, NIAID, USAID, DARPA, DTRA, EcoHealth Alliance, universities and private contractors built the international pathogen-research network.
Sources and Documents
Primary and official material
- US Department of Health and Human Services Office of Inspector General audit of NIH and EcoHealth Alliance.
- US Department of Defense records concerning Cooperative Threat Reduction and biological-security programmes in Ukraine.
- Senate Foreign Relations Committee hearing featuring Victoria Nuland.
- Office of the Director of National Intelligence releases from 2023 and 2026.
- House Select Subcommittee material concerning Anthony Fauci, NIH oversight and gain-of-function terminology.
- Presidential clemency records concerning Anthony Fauci and Hunter Biden.
Supporting material
- Congressional testimony and scientific communications analysed in Dr Robert W. Malone’s July 2026 article, Ralph Baric Just Blew Up the Official COVID Origins Narrative.
- Public reporting and corporate material concerning Metabiota, Black & Veatch and Ukraine biological-security programmes.